本页面由Tiger Trade Technology Pte. Ltd.提供服务

Sol-Gel Technologies

73.15
+1.752.44%
成交量:1.12万
成交额:80.37万
市值:2.39亿
市盈率:-33.26
高:75.00
开:71.07
低:71.07
收:71.40
52周最高:97.97
52周最低:4.11
股本:326.90万
流通股本:70.92万
量比:0.51
换手率:1.58%
股息:- -
股息率:- -
每股收益(TTM):-2.1993
每股收益(LYR):-2.1993
净资产收益率:-23.72%
总资产收益率:-14.43%
市净率:10.48
市盈率(LYR):-33.26

数据加载中...

公司资料

公司名字:
Sol-Gel Technologies
交易所:
NASDAQ
成立时间:
1997
员工人数:
28
公司地址:
7 Golda Meir Street,Weizmann Science Park,Ness Ziona,Israel
邮编:
7403650
传真:
- -
简介:
Sol-gel Technologies Ltd.1997年10月28日根据以色列国法律注册成立。该公司是一家创新型皮肤病学公司,拥有两项NDA批准的成功记录,以及正在为孤儿适应症开发的先进候选产品管道。Sol-Gel成功研发开创性外用药物Twyneo和Epsolay,分别获批用于红斑痤疮和炎症性病变的治疗。

董事

名称
职位
Moshe Arkin
Executive Chairman of the Board and interim Chief Executive Officer
Ran Gottfried
Lead Independent Director
Sharon Kochan
Independent Director
Yuval Yanai
Independent Director
Hani Lerman
Director
Itai Arkin
Director

股东

名称
职位
Moshe Arkin
Executive Chairman of the Board and interim Chief Executive Officer
Itzik Yosef
Chief Operating Officer
Eyal Ben Or
Chief Financial Officer
Michael Glezin
Chief Business Officer
Ofer Toledano
Vice President Research and Development
Ofra Levy Hacham
Vice President Clinical, Regulatory Affairs and Quality